Gpt Healthcare Limited · NSE:GPTHEALTH
Gpt Healthcare — Q2 & H1 FY25 Earnings Presentation
27 slides from Gpt Healthcare's earnings presentation, Nov 14, 2024
Slide 1: Exchange filing cover letter
GPT Healthcare Limited Regd. Office: GPT Centre, JC-25, Sector III, Salt Lake, Kolkata – 700 106, India CIN : L70101WB1989PLC047402 Phone : +91-33-4050-7000, Email : info@gptgroup.co.in , Visit us: www.gptgroup.co.in GPTHEALTH/CS/SE/2024-25 November 14, 2024 The Department of Corporate Services Nati
Slide 2: Investor Presentation – Q2 & H1FY25
GPT Healthcare Limited Investor Presentation – Q2 & H1FY25 N S E : G P T H E A LT H | B S E : 5 4 4 1 3 1
Slide 3: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by GPT Healthcare Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any secur
Slide 4: Table of Content
Table of Content Q2 & H1FY25 Company Overview Business Highlights Annual Financials Performance 3
Slide 5: Q2 & H1FY25 Performance
Q2 & H1FY25 Performance \ = 7 \« LS " ¥ . \
Slide 6: Robust Performance Continues – Q2 & H1FY25
Robust Performance Continues – Q2 & H1FY25 Revenue from Operations EBITDA & EBIDTA Margin PAT & PAT Margin Rs 26.3 Cr Rs 14.8 Cr Rs 105.7 Cr Q2FY25 Q2FY25 Q2FY25 (24.4% Margin) (13.8% Margin) 8.1% QoQ 30% QoQ 48.2% QoQ 2.1% YoY 2.2% YoY 9.8% YoY Rs 46.4 Cr Rs 24.7 Cr Rs 203.5 Cr H1FY25 H1FY25 H1FY25
Slide 7: Financial Highlights – H1FY25
Financial Highlights – H1FY25 Net Profit: Rs 24.7 Cr 53% Tax: Rs 10.6 Cr 23% 22% EBITDA : Depreciation: Rs 9.5 Cr 20% Rs 46.4 Cr Finance Costs Rs 1.6 Cr 3% Total Income : Medicines and Consumables: 24% 100% Rs 208.5 Cr Rs 38.7 Cr __% Employee Benefit Costs : Rs 36.5 Cr 23% Total Expenses: Rs 162.2 C
Slide 8: Hospital wise Performance – Q2 & H1FY25
Hospital wise Performance – Q2 & H1FY25 Bed Occupancy Rate ARPOB Year of Bed Capacity (%) (Rs Per day) Data as of Q2FY25 Commission (No. of Beds) Q2FY25 H1FY25 Q2FY25 H1FY25 59.8% 58.0% Salt Lake Hospital 2000 85 39,172 39,491 47.3% 46.9% Agartala Hospital 2011 205 33,105 32,423 70.8% 70.2% Dum Dum
Slide 9: Profit & Loss Highlights – Q2FY25
Profit & Loss Highlights – Q2FY25 Particulars (Rs Cr) Q2FY25 Q2FY24 YoY Q1FY25 QoQ H1FY25 H1FY24 YoY Revenue from operations 105.7 108.0 -2.1% 97.8 8.1% 203.5 204.2 -0.3% Other Income 2.8 1.1 154.5% 2.2 27.3% 5.0 2.5 101.6% Total Income 108.5 109.1 -0.5% 100.1 8.4% 208.5 206.7 0.9% Cost of materials
Slide 10: Growth Drivers in Place
Growth Drivers in Place Continued Investment in Infrastructure New Hospital ✓ Installed cutting-edge robotic surgical Existing Hospitals technology in Salt Lake Hospital and ✓ Setting up hospitals on Asset-light basis performed 480+ robotic surgeries where investment in land and building constructio
Slide 11: Company Overview
Company Overview
Slide 12: Key regional corporate healthcare companies in Eastern India
GPT Healthcare – Key regional corporate healthcare companies in Eastern India ✓ Strategically located in Densely Populated Micro Markets of Kolkata and Howrah, and Agartala ✓ Established Right-Sized, Full-Service Hospitals according to each sub-region, aids High Return on Capital 561 90 560 4 NABH &
Slide 13: Salt Lake Hospital (Year 2000)
Salt Lake Hospital (Year 2000) Total 85 Beds, including 17 Beds across ICUs and HDUs along with 3 OTs The Department of Minimal Access Surgery is accredited by National Board of Examinations for training of post-graduate surgeons under the Fellowship of National Board in Minimal Access Surgery Award
Slide 14: Agartala Hospital (Year 2011)
Agartala Hospital (Year 2011) Total 205 Beds, including 66 Beds across ICUs along with 8 OTs & 1 catheterization laboratory The only NABH accredited hospital in Agartala and one among 11 valid accredited hospitals in North-East India as of October 2023. Also accredited by NABL Received the ‘Excellen
Slide 15: Dum Dum Hospital (Year 2013)
Dum Dum Hospital (Year 2013) Total 155 Beds, including 53 Beds across ICUs and HDUs along with 4 OTs & 1 catheterization laboratory NABH accredited and NABL accredited for complying with ISO 15189:2012 standards in the field of medical testing Recognized by the CII for Excellence in Nursing for thei
Slide 16: Howrah Hospital (Year 2019)
Howrah Hospital (Year 2019) Total 116 Beds, including 43 Beds across ICUs and HDUs along with 3 OTs & 1 catheterization laboratory Located in close proximity to the Howrah railway station and enjoys a strong locational advantage Recognized by the CII for Excellence in Nursing for their efforts, comm
Slide 17: Business Highlights
Business Highlights
Slide 18: Focused on High Return on Capital – Factors that lead to it
Focused on High Return on Capital – Factors that lead to it Strategic Location Disciplined Approach Brand Strength Right Sized, towards Costs demonstrated through of the Hospitals Full Service Payor Mix Being in populous neighbourhoods Operating multispecialty, mid sized Strategic measures towards V
Slide 19: Professional and experienced leadership – Board of Directors
Professional and experienced leadership – Board of Directors Dwarika Prasad Tantia Dr. Om Tantia Anurag Tantia Dr. Aruna Tantia Dr. Ghanshyam Goyal Chairman & Wholetime Director Managing Director Whole-time Director Non - Executive Director Non - Executive Director C C M M M M M • Founding member of
Slide 20: Annual Performance
| Annual Performance
Slide 21: Key Financial Metrics
Key Financial Metrics Revenue from Operations (Rs Cr) EBITDA & EBIDTA Margin PAT & PAT Margin 23.0% 23.0% 12.2% 21.8% 22.3% 22.3% 11.9% 400 11.8% 361 11.4% 337 42 204 204 39 48 46 24 25 46 79 80 93 10.6% FY22 FY23 FY24 H1FY24 H1FY25 FY22 FY23 FY24 H1FY24 H1FY25 FY22 FY23 FY24 H1FY24 H1FY25 EBITDA (R
Slide 22: Key Operational Metrics
Key Operational Metrics No. of Beds & Occupancy Rate (%) Average Length of Stay (ALOS) Average Revenue per Occupied Bed (ARPOB) (in Rs per day) 59.9% 36,676 58.9% 58.9% 32,947 32,979 53.70% 29,253 29,671 56.4% 4.80 556 561 561 561 561 4.22 3.95 3.98 3.51 FY22 FY23 FY24 H1FY24 H1FY25 FY22 FY23 FY24 H
Slide 23: Profit & Loss
Profit & Loss Particulars (Rs Cr) FY23 FY24 H1FY25 Revenue from operations 361.0 400.2 203.5 Other Income 5.7 5.3 5.0 Total Income 366.7 405.5 208.5 Cost of materials consumed 75.9 83.0 38.7 Employee benefits expense 62.0 68.9 36.5 Other expenses 148.8 160.5 87.0 EBITDA 80.0 93.1 46.4 EBITDA Margin
Slide 24: Balance Sheet
Balance Sheet Assets (Rs Cr) Mar-23 Mar-24 Sep-24 Liabilities (Rs Cr) Mar-23 Mar-24 Sep-24 PPE 203.7 201.1 198.7 Share Capital 79.9 82.1 82.1 Other Equity 85.5 136.4 148.9 Other Non-Current Asset 36.6 45.1 55.4 Total Equity 165.4 218.5 231 Investments 5.2 19.2 22.9 Borrowings 40.3 3.6 2.3 Non-Curren
Slide 25: Cash Flow Statement
Cash Flow Statement Particulars (in Cr) Mar-23 Mar-24 Sep-24 Cash Flow from Operating Activities Profit before Tax 56.0 68.0 35.4 Adjustment from Non-Operating Items Operating Profit before Working Capital 74.6 90.0 44.1 (Increase)/decrease in Inventories -1.6 0.8 -0.9 (Increase)/decrease in Trade R
Slide 26: Stock Information
Stock Information Share Price Movement Shareholding Pattern (as on September-24) 250 25,000 29-Feb-2024 Listing Date Public 2nd Interim 18.9% Promoters 200 Dividend of Re.1 /- 20,000 DII 65.6% Final Dividend of Rs. 1.5/- 10.8% FII 150 15,000 4.7% Price in Rs Volumes (in ‘000) 100 10,000 Promoters FI
Slide 27: Thank you
Thank ou GPT Healthcare Limited Stellar IR Advisors Pvt. Ltd. CIN No.: U70101WB1989PLC047402 Contact No.: 022 62398024 Mr. Anurag Tantia, Executive Director Ms. Pooja Sharma anurag@gptgroup.co.in pooja.sharma@stellar-ir.com ghl.cosec@gptgroup.co.in Mr. Akhilesh Gandhi akhilesh@stellar-ir.com For mor